SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-24-000118
Filing Date
2024-04-30
Accepted
2024-04-30 12:04:51
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20240331.htm   iXBRL 10-Q 1528613
2 EX-31.1 lly-03312024x10qxexhibit311.htm EX-31.1 10589
3 EX-31.2 lly-03312024x10qxexhibit312.htm EX-31.2 10620
4 EX-32 lly-03312024x10qxexhibit32.htm EX-32 7074
  Complete submission text file 0000059478-24-000118.txt   8818617

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20240331.xsd EX-101.SCH 45475
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20240331_cal.xml EX-101.CAL 71540
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20240331_def.xml EX-101.DEF 246979
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20240331_lab.xml EX-101.LAB 602073
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20240331_pre.xml EX-101.PRE 425489
76 EXTRACTED XBRL INSTANCE DOCUMENT lly-20240331_htm.xml XML 1870086
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 24895249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)